参考文献/References:
[1]王征,樊嘉,周俭.ALPPS在肝脏外科的应用前景[J].肝胆外科杂志,2015,23(1):1-2.
[2]Sotiropoulos GC,Lang H,Frilling A,et al.Resectability of hepatocellular carcinoma:evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature[J].Hepato-gastroenterology,2006,53(53):322-329.
[3]Jiang FQ,Wei L,Chao Y.Curative effect of transcatheter arterial chemoembolization combined with radiofrequency ablation in treating hepatic cell carcinoma and the effect on serum markers [J].Cancer Biomarkers,2016,22(8):86-90.
[4]Siriapisith T,Siwasattayanon P,Tongdee T.Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma[J].J Med Assoc Thai,2012,95(3):430.
[5]陈敏山,张耀军.射频消融在肝癌多学科综合治疗中的应用[C]//全国临床肿瘤学大会暨2010年CSCO学术年会.2010.
[6]Feng K,Yan J,Li X,et al.A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J].Journal of Hepatology,2012,57(4):794-802.
[7]Pompili M,Saviano A,Matthaeis ND,et al.Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma≤3 cm.Results of a multicenter Italian survey[J].Journal of Hepatology,2013,59(1):89-97.
[8]Qi X,Tang Y,An D,et al.Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma:a meta-analysis of randomized controlled trials[J].Journal of Clinical Gastroenterology,2014,48(5):450.
[9]Choe WH,Kim YJ,Park HS,et al.Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma[J].World Journal of Gastroenterology,2014,20(35):12588.
[10]Roauaie S,Obeidat K,Sposito C,et al.Resection of Hepatocellular Cancer≤2 cm:Results from Two Western Centers[J].Hepatology,2013,57(4):1426-1435.
[11]Zhang N,Wang L,Chai ZT,et al.Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling[J].Plos One,2014,9(12):e115949.
[12]王松,姜凯.肝癌射频消融过程中热效应的研究现状[J].世界肿瘤研究,2016,6(4):31-35.
[13]Hyun D,Cho SK,Shin SW,et al.Treatment of Small Hepatocellular Carcinoma(≤2 cm)in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation[J].Cardiovascular&Interventional Radiology,2016,39(7):1015-1022.
[14]姬统理,杜锡林,李刚,等.肝动脉化疗栓塞术加经皮肝穿刺射频消融术治疗原发性肝癌56例[J].现代肿瘤医学,2004,12(6):540-541.
[15]Groeschl RT,Gamblin TC,Turaga KK.Ablation for Hepatocellular Carcinoma:Validating the 3 cm Breakpoint[J].Annals of Surgical Oncology,2013,20(11):3591-3595.
[16]Peng ZW,Zhang YJ,Chen MS,et al.Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma:A Prospective Randomized Trial[J].Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology,2013,31(4):426.
[17]Morimoto M,Numata K,Kondou M,et al.Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma:a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization[J].Cancer,2010,116(23):5452.
[18]中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2017年版)[J].中华消化外科杂志,2017,16(7):705-720.
[19]王瑜.射频消融后辅助肝动脉化疗栓塞治疗早期肝癌的前瞻性随机对照研究[D].第三军医大学,2015.
[20]高松学,任伟新.肝动脉化疗栓塞术联合射频消融治疗肝癌的现状[J].中国介入影像与治疗学,2010,07(6):680-683.
[21]Liu H,Wang ZG,Fu SY,et al.Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria[J].British Journal of Surgery,2016,103(4):348-356.
[22]Takaki H,Yamakado K,Uraki J,et al.Radiofrequency Ablation Combined with Chemoembolization for the Treatment of Hepatocellular Carcinomas Larger than 5 cm [J].Journal of Vascular&Interventional Radiology,2009,20(2):217-224.
[23]Kuroda H,Kasai K,Kakisaka K,et al.Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma[J].Hepatology Research the Official Journal of the Japan Society of Hepatology,2010,40(5):550.
[24]Li JX,Wu H,Huang JW,et al.The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma[J].J Formos Med Assoc,2012,111(9):510-515.
[25]Koda M,Ueki M,Maeda Y,et al.The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma[J].Hepatology Research the Official Journal of the Japan Society of Hepatology,2004,29(1):18-23.
[26]Kang SG,Yoon CJ,Jeong SH,et al.Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study[J].Journal of Vascular&Interventional Radiology Jvir,2009,20(12):1570-1577.
[27]Lencioni R,Llovet JM.Modified RECIST(mRECIST)assessment for hepatocellular carcinoma[J].Seminars in Liver Disease,2010,30(1):52.
[28]Shao GL,Zheng JP,Guo LW,et al.Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging:A prospective study[J].Medicine,2017,96(3):e5518.
[29]邓士杰,高纪称,王海屹.CT和MRI对射频消融联合肝动脉化疗栓塞治疗肝细胞肝癌疗效评价的对比研究[J].山西医药杂志,2014,43(3):261-263.
[30]赵炜.GD-EOB-DTPA增强MRI对肝癌患者TACE-RFA术后疗效评估的研究[D].南方医科大学,2015.
[31]Kamiyama T,Yokoo H,Kakisaka T,et al.Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-Ⅱ is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy[J].Hepatology Research,2015,45(10):E21-E31.
[32]An SL,Xiao T,Wang LM,et al.Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors:a Single-center Experience from China[J].Asian Pacific Journal of Cancer Prevention Apjcp,2015,16(10):4421-4427.
[33]Meng W,Li X,Bai Z,et al.Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell[J].Plos One,2014,9(2):e90660.
[34]Yamada R,Hiramatsu N,Oze T,et al.Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection[J].Journal of Gastroenterology,2015,50(7):785.
[35]Z H,W Z.Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma[J].Cellular&Molecular Immunology,2012,9(1):7.
[36]Veltri A,Moretto P,Doriguzzi A,et al.Radiofrequency thermal ablation(RFA)after transarterial chemoembolization(TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma(HCC)[J].European Radiology,2006,16(3):661.
[37]Yan S,Xu D,Sum B.Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma:a meta-analysis[J].Digestive Diseases&Sciences,2012,57(11):3026-3031.
[38]Qi X,Zhao Y,Li H,et al.Management of hepatocellular carcinoma:an overview of major findings from meta-analyses[J].Oncotarget,2016,7(23):34703.
[39]Liu Z,Gao F,Yang G,et al.Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma:an up-to-date meta-analysis[J].Tumour Biology the Journal of the International Society for Oncodevelopmental Biology&Medicine,2014,35(8):1-7.
[40]黄文浩.肝动脉介入化疗栓塞与射频消融联合治疗肝癌的研究分析[J].中国卫生标准管理,2015,6(14):24-25.
相似文献/References:
[1]韩林东,李 明.青少年特发性脊柱侧弯非手术治疗研究进展[J].医学信息,2018,31(08):28.[doi:10.3969/j.issn.1006-1959.2018.08.010]
HAN Lin-dong,LI Ming.Progress in Non-operative Treatment of Adolescent Idiopathic Scoliosis[J].Journal of Medical Information,2018,31(09):28.[doi:10.3969/j.issn.1006-1959.2018.08.010]
[2]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Journal of Medical Information,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Journal of Medical Information,2019,32(09):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Journal of Medical Information,2018,31(09):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Journal of Medical Information,2018,31(09):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的
相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Journal of Medical Information,2019,32(09):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(09):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[8]孙 逊.性化护理对肝癌患者CT引导下射频消融术后
负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after
CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(09):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[9]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(09):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[10]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(09):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]